Dis-Chem Pharmacies (DCP/ZAC) Stock Price

  • Exchange: JSE
  • Industry: Pharmaceutical Retailers
Dis-Chem Pharmacies Dis-Chem Pharmacies
Price in
ZAC
ZAC
2,817
-0.53%
At close 10/23
Buy now

Your capital is at risk.

Loading...
  • Open ZAC 2,844
  • Low ZAC 2,774
  • High ZAC 2,862
  • Prev. Close ZAC 2,832

Technical Outlook

Neutral

Overall signal across
25 indicators

  • Moving Averages
    Buy 0
    Sell 0
  • Indicators
    Buy 0
    Sell 0
  • Timeframe

Similar Companies

TU Stock Score

5.8 of 10
Neutral

TU Stock Score summarizes key factors to assess overall investment attractiveness.

  • Financial Health
    5.3\10
  • Valuation
    5.2\10
  • Outlook
    N/A
  • Momentum
    5.5\10
  • Analyst Consensus
    6.1\10
  • Risk
    8.4\10
  • Strongest Factor Risk

    Relatively low market risk profile.

  • Weakest Factor Valuation

    Valuation is less attractive than other factors.

  • Score Relative to Sector Top 26%

    Higher than 74% of companies in the Healthcare sector.

TU Stock Score

The TU Stock Score is a unique analytical rating developed by the TU team of analysts, led by Anton Kharitonov, to provide a simple, comprehensive assessment of a stock on a 0–10 scale, with key fundamental and valuation metrics evaluated relative to companies in the same sector.

It was created to help investors quickly understand a stock’s strengths and weaknesses without having to analyze dozens of fundamental, valuation, technical, and analyst metrics separately.

The score combines six factors: Financial Health (25%), Valuation (20%), Outlook (20%), Momentum (15%), Analyst Consensus (10%), and Risk (10%). Each factor is scored from 0 to 10, with higher scores indicating a more favorable result. The final TU Stock Score is calculated as a weighted average of these factors.

· 6.0–10.0 — Bullish · 4.0–5.9 — Neutral · 0–3.9 — Bearish

The TU Stock Score is an analytical rating and does not constitute investment advice.

Evaluates profitability, financial strength, debt levels, and revenue growth relative to sector peers.

Evaluates how the stock is valued relative to other companies in its sector.

Evaluates expected EPS and revenue growth and forward valuation relative to sector peers.

Measures current stock momentum based on aggregated daily technical signals.

Reflects the overall sentiment of analysts covering the stock.

Risk Score measures market risk based on Beta and average daily price range. A higher score means lower market risk.

Where to buy Stocks

Broker
Stocks
Yes
ETFs
Yes
Account min.
50
Safety
7.1/10
Users Picked
1589
Action
Trade

Your capital is at risk.

Stocks
Yes
ETFs
Yes
Account min.
2,500​
Safety
9.2/10
Users Picked
952
Action
Trade

Your capital is at risk.

Stocks
Yes
ETFs
Yes
Account min.
500
Safety
10/10
Users Picked
2410
Action
Trade

Your capital is at risk.

Users picked this company on TU in the last 3 months.

Shows the broker`s regulation and safety level based on factors such as tier-1 regulation and investor protection. Learn how we evaluate brokers.

Analyst Consensus

Updated:
Hold

Based on 30 analysts

Trade

Your capital is at risk.

Average Target Price
ZAC 3.6K 28%
Target Price Range
ZAC 2.5K Lowest ZAC 4.3K Highest

Analyst Consensus is based on aggregated ratings and price targets from analysts covering the stock. The block shows the overall consensus, number of analysts, average target price, and the range between the lowest and highest analyst price targets.

Earnings

Estimated Next Earnings

EPS Estimate
ZAC 0.79
Revenue Estimate
ZAC 21.3B
Beat Rate
33% 2/6 quarters
Average Surprise
-2.6%
Earnings Summary

Dis-Chem Pharmacies has delivered an average EPS surprise of -2.6% over its recent quarterly reports. Analysts currently expect EPS of ZAC 0.79 and revenue of ZAC 21.3B in the next quarterly report.

Key data for the upcoming earnings report, including analyst EPS and revenue estimates and the company’s recent earnings performance.

Dis-Chem Pharmacies (DCP) Fundamentals

Updated:
Financial Performance
Revenue ZAC 42.8B
Net Income ZAC 978.9M
Free Cash Flow N/A
Operating Margin 3.38%
Net Margin 2.29%
ROE 18.96%
Fundamentals Summary

Compared with other companies in its sector, Dis-Chem Pharmacies shows average financial health compared with sector peers based on its profitability and balance sheet metrics. Its valuation is broadly in line with sector peers.

Technical Outlook

Neutral

Overall signal across
25 indicators

  • Moving Averages
    Buy 0
    Sell 0
  • Indicators
    Buy 0
    Sell 0
  • Timeframe

DCP/ZAC Performance

Period Change Change %
1 D -ZAC 15 -0.53%
1 W ZAC 90 3.3%
1 M ZAC 151 5.66%
3 M -ZAC 168 -5.63%
1 Y -ZAC 591 -17.34%

Dis-Chem Pharmacies About Dis-Chem Pharmacies

Dis-Chem Pharmacies (DCP) is a South African retail healthcare group operating a nationwide network of pharmacy stores. Its principal business is the sale of prescription medicines, over-the-counter pharmaceutical products, health supplements, personal care and beauty products, and selected convenience items. The company also provides primary healthcare services through in-store clinics, where qualified healthcare professionals deliver basic medical services. Dis-Chem Pharmacies supports its retail operations with centralised wholesale and distribution infrastructure. These operations supply the group’s stores and serve selected external customers, creating an integrated retail and supply-chain model.

Investment Return Calculator

Return Calculator (Historical)
ROI RESULT
 
 
ROI shows how effectively your investment performed — how much profit or loss it generated over the selected period.

FAQs

  • What is the current Dis-Chem Pharmacies (DCP) stock price?

    As of Oct 25, 2026, Dis-Chem Pharmacies (DCP) stock is trading at ZAC 2,817 ZAC.

  • Which stock exchange is Dis-Chem Pharmacies listed on?

    Apple is listed on the JSE stock exchange.

  • What is Dis-Chem Pharmacies’s stock ticker symbol?

    The stock ticker for Dis-Chem Pharmacies is DCP.

  • Does Dis-Chem Pharmacies pay dividends? What’s the yield?

    Yes, Dis-Chem Pharmacies pays dividends. The current dividend yield is 1.61%.

  • What is Dis-Chem Pharmacies’s market capitalization?

    Dis-Chem Pharmacies’s current market cap stands at approximately ZAC 24.1B.

  • What is Dis-Chem Pharmacies’s earnings per share (EPS)?

    Dis-Chem Pharmacies’s trailing twelve-month (TTM) EPS is ZAC 2.5.

  • What is the analyst price target for Dis-Chem Pharmacies (DCP)?

    The 12-month average price target for Dis-Chem Pharmacies is ZAC 3,607, with a high estimate of ZAC 4,310 and a low of ZAC 2,500.

  • How volatile is Dis-Chem Pharmacies’s (DCP) stock right now?

    During the latest trading session on Oct 25, 2026, Dis-Chem Pharmacies (DCP) moved within a daily range of ZAC 2,774-ZAC 2,862 and has fluctuated within a 52-week range of ZAC 2,536-ZAC 3,900.

Disclaimer

All information on the pages containing forecasts, video forecasts, and other analytical materials is published ‘as is’ and for informational purposes only. The information is not intended for trading or advice of financial, investment, tax, legal, accounting or any kind of nature. Before starting to trade, please contact your broker or a financial advisor to check the quotes, evaluate forecasts or the opinion of the author of the article. Our company is not an investment consultant, financial advisor or a broker for transactions involving securities. No information shall be viewed as investment advice, recommendation or offer of our company to buy, hold or sell securities or financial products. Our company does not provide guarantees and does not express opinions about appropriateness or suitability of investments.

No information shall be regarded as investment advice (general or individual). Financial products or transactions mentioned in such information may not be suitable for your investment portfolio and may not meet your investment targets and expectations. You are solely responsible for any decision regarding financial products or transactions and you shall independently determine whether they are suitable for you, taking into account your interests, investment targets, investment horizon and tolerable risk level. Our company shall not bear any responsibility for the losses caused by financial transactions or investments in financial products mentioned on our website. We do not recommend making investment decisions guided solely by this information.

The information on our website is provided by stock exchanges, brokers and other content providers, and, in some cases, may arrive with a delay. Our company does not verify such information and shall waive any liability related to it.

Our company and our information and content providers, financial exchanges, brokers and also all affiliated companies and business partners: a) expressly waive any responsibility for the accuracy, validity and completeness of any data; b) shall not be liable for any mistakes, omissions or other flaws on such information, for delays and interruptions in their display, as well as for actions taken based on such information. Neither our company nor our information providers shall be liable for the damage caused by the use of the information provided here. The term ‘business partners’ in this case shall not imply any partnership or agency relationships as well as the creation of a joint venture between our company and any other organization.

You hereby confirm that you shall not copy, modify, reformat, download, store, reproduce, process, transfer or distribute any information published here or use such information for commercial purposes without prior written consent.

Traders Union as well as its external information and content providers retain exclusive copyright to the provided information.

Our company shall not be liable for the products and services advertised on our website.

General websites Disclaimer:

Traders Union (tradersunion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it. Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.

Risk disclosure:

Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit.

That is why you should only invest money you are willing and able to lose, given the high level of risk involved. Tradersunion.com does not offer financial services, including investment or financial advisory services. Traders Union is not a broker and does not receive compensation for trading in the Forex or CFD markets. Our website only provides informational content about brokers and financial markets and helps users choose the most suitable brokerage company based on comprehensive data and objective analysis..

Prise Analysis and Forecasting Methodology

Traders Union displays real-time stock prices and market data using third-party providers, primarily Twelve Data and Financial Modeling Prep (FMP). Company fundamentals, earnings data, analyst estimates, price targets, and other market metrics are also sourced from external financial data providers. Providers may be replaced when necessary to ensure continuous market coverage.